Thinking of joining a study?

Register your interest

NCT05138991 | Recruiting | Hematopoietic and Lymphoid Cell Neoplasm


Reproducibility and Accuracy of a Portable System for Early Detection of Cardiac Dysfunction in Childhood Cancer Survivors
Sponsor:

City of Hope Medical Center

Brief Summary:

The clinical trial compares the reproducibility and accuracy of cardiac tonometry-based portable systems that may detect early cardiac dysfunction (SphygmoCor® Xcel and Oscar 2™ ambulatory blood pressure monitor) at home and in the clinic to currently available screening tests for heart failure including echocardiogram (echo) and cardiovascular magnetic resonance (CMR). The SphygmoCor® Xcel and Oscar 2™ systems may help detect cardiac dysfunction earlier than other available screening tests because it can be self-administered outside of the clinic. This study aims to test the accuracy and practicality of these devices in the clinic setting and at home.

Condition or disease

Hematopoietic and Lymphoid Cell Neoplasm

Malignant Solid Neoplasm

Intervention/treatment

Echocardiogram Recording

Questionnaire Administration

Stress Cardiac Magnetic Resonance Imaging

Wireless Synchronized Cardiac Function Monitoring Device

Phase

Not Applicable

Detailed Description:

Primary Objective(s) Validate the accuracy of ejection fraction, as measured using a tonometry-based system (SphygmoCor® Xcel), in the clinic setting, and determine the reproducibility (Oscar 2™) at home. Secondary Objective(s) Determine the cost-effectiveness of tonometry-based screening in the clinic setting and at home.}}

Study Type : Interventional
Estimated Enrollment : 200 participants
Masking : None (Open Label)
Primary Purpose : Screening
Official Title : Assessment of the Reproducibility and Accuracy of a Portable System for Early Detection of Cardiac Dysfunction in Childhood Cancer Survivors
Actual Study Start Date : June 22, 2022
Estimated Primary Completion Date : November 15, 2024
Estimated Study Completion Date : November 15, 2024
Arm Intervention/treatment

Experimental: Screening (echo, CMR, Tonometry-based system)

Patients undergo a one time assessment of cardiac function by echo, CMR, and the Tonometry-based system system in the clinic over 4-6 hours, and will be asked to perform their home-based measurements within 1-5 days of the clinical assessment, allowing us to directly compare measurements obtained by survivors to those by research personnel. Patients also complete questionnaires at baseline.

Procedure: Echocardiogram Recording

Other: Questionnaire Administration

Procedure: Stress Cardiac Magnetic Resonance Imaging

Device: Wireless Synchronized Cardiac Function Monitoring Device

Ages Eligible for Study:
Sexes Eligible for Study: All
Accepts Healthy Volunteers: Accepts Healthy Volunteers
Criteria
Inclusion Criteria
  • Previously enrolled in IRB# 14154.
  • Able to understand and sign the study specific informed consent form (ICF).
Exclusion Criteria
  • Participants cannot be actively receiving cancer-directed therapy.
  • Standard exclusion criteria for CMR imaging will be incorporated, and these include: implanted pacemaker or defibrillator, insulin pump, cochlear implant, central nervous system aneurismal clips, implanted neural stimulator, ocular foreign body (metal), other implanted medical devices (e.g.: drug infusion ports).

Reproducibility and Accuracy of a Portable System for Early Detection of Cardiac Dysfunction in Childhood Cancer Survivors

Location Details


Please Choose a site



Reproducibility and Accuracy of a Portable System for Early Detection of Cardiac Dysfunction in Childhood Cancer Survivors

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Recruiting

United States, California

City of Hope Medical Center

Duarte, California, United States, 91010

Loading...